JP2019501363A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501363A5 JP2019501363A5 JP2018516113A JP2018516113A JP2019501363A5 JP 2019501363 A5 JP2019501363 A5 JP 2019501363A5 JP 2018516113 A JP2018516113 A JP 2018516113A JP 2018516113 A JP2018516113 A JP 2018516113A JP 2019501363 A5 JP2019501363 A5 JP 2019501363A5
- Authority
- JP
- Japan
- Prior art keywords
- cysteine
- protein
- reactive probe
- moiety
- reactive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 27
- 235000018102 proteins Nutrition 0.000 claims 18
- 108090000623 proteins and genes Proteins 0.000 claims 18
- 102000004169 proteins and genes Human genes 0.000 claims 18
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 14
- 235000018417 cysteine Nutrition 0.000 claims 14
- 239000000523 sample Substances 0.000 claims 13
- 150000003384 small molecules Chemical group 0.000 claims 10
- 210000004027 cell Anatomy 0.000 claims 5
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 4
- -1 N-hydroxysuccinimide (NHS) ester Chemical class 0.000 claims 3
- JVJFIQYAHPMBBX-UHFFFAOYSA-N 4-hydroxynonenal Chemical compound CCCCCC(O)C=CC=O JVJFIQYAHPMBBX-UHFFFAOYSA-N 0.000 claims 2
- 150000001345 alkine derivatives Chemical group 0.000 claims 2
- 238000004458 analytical method Methods 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- VHRUMKCAEVRUBK-GODQJPCRSA-N 15-deoxy-Delta(12,14)-prostaglandin J2 Chemical compound CCCCC\C=C\C=C1/[C@@H](C\C=C/CCCC(O)=O)C=CC1=O VHRUMKCAEVRUBK-GODQJPCRSA-N 0.000 claims 1
- 102000004506 Blood Proteins Human genes 0.000 claims 1
- 108010017384 Blood Proteins Proteins 0.000 claims 1
- 108010078791 Carrier Proteins Proteins 0.000 claims 1
- 108091006146 Channels Proteins 0.000 claims 1
- 102000034573 Channels Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims 1
- 102000006404 Mitochondrial Proteins Human genes 0.000 claims 1
- 108010058682 Mitochondrial Proteins Proteins 0.000 claims 1
- 108010006519 Molecular Chaperones Proteins 0.000 claims 1
- 108091005764 adaptor proteins Proteins 0.000 claims 1
- 102000035181 adaptor proteins Human genes 0.000 claims 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 claims 1
- 150000001336 alkenes Chemical class 0.000 claims 1
- 125000005262 alkoxyamine group Chemical group 0.000 claims 1
- 150000001540 azides Chemical class 0.000 claims 1
- 150000001718 carbodiimides Chemical class 0.000 claims 1
- 210000004292 cytoskeleton Anatomy 0.000 claims 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims 1
- 125000005179 haloacetyl group Chemical group 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- RDBMUARQWLPMNW-UHFFFAOYSA-N phosphanylmethanol Chemical compound OCP RDBMUARQWLPMNW-UHFFFAOYSA-N 0.000 claims 1
- 238000000575 proteomic method Methods 0.000 claims 1
- 108091006024 signal transducing proteins Proteins 0.000 claims 1
- 102000034285 signal transducing proteins Human genes 0.000 claims 1
- GWIKYPMLNBTJHR-UHFFFAOYSA-M thiosulfonate group Chemical group S(=S)(=O)[O-] GWIKYPMLNBTJHR-UHFFFAOYSA-M 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562244881P | 2015-10-22 | 2015-10-22 | |
| US62/244,881 | 2015-10-22 | ||
| US201662345710P | 2016-06-03 | 2016-06-03 | |
| US62/345,710 | 2016-06-03 | ||
| PCT/US2016/058308 WO2017070611A1 (en) | 2015-10-22 | 2016-10-21 | Cysteine reactive probes and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501363A JP2019501363A (ja) | 2019-01-17 |
| JP2019501363A5 true JP2019501363A5 (https=) | 2020-01-30 |
| JP6953400B2 JP6953400B2 (ja) | 2021-10-27 |
Family
ID=58558160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018516113A Active JP6953400B2 (ja) | 2015-10-22 | 2016-10-21 | システイン反応性プローブとその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10670605B2 (https=) |
| EP (1) | EP3365686A4 (https=) |
| JP (1) | JP6953400B2 (https=) |
| CA (1) | CA3001847A1 (https=) |
| WO (1) | WO2017070611A1 (https=) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10782295B2 (en) | 2013-08-13 | 2020-09-22 | The Scripps Research Institute | Cysteine-reactive ligand discovery in proteomes |
| JP6953400B2 (ja) * | 2015-10-22 | 2021-10-27 | ザ スクリプス リサーチ インスティテュート | システイン反応性プローブとその使用 |
| JP7039489B2 (ja) | 2016-05-18 | 2022-03-22 | ミラティ セラピューティクス， インコーポレイテッド | Ｋｒａｓ ｇ１２ｃ阻害剤 |
| WO2017210600A1 (en) * | 2016-06-03 | 2017-12-07 | The Scripps Research Institute | Compositions and methods of modulating immune response |
| IL268101B2 (en) | 2017-01-18 | 2024-08-01 | Scripps Research Inst | Photoreactive ligands and their uses |
| KR20190126074A (ko) * | 2017-02-03 | 2019-11-08 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 레티쿨론 4를 억제하기 위한 조성물 및 방법 |
| MX2019009199A (es) * | 2017-02-03 | 2019-10-21 | Univ California | Composiciones y métodos para modular ppp2r1a. |
| WO2018144869A1 (en) * | 2017-02-03 | 2018-08-09 | The Regents Of The University Of California | Compositons and methods for modulating uba5 |
| US20200278355A1 (en) * | 2017-09-27 | 2020-09-03 | The Scripps Research Institute | Conjugated proteins and uses thereof |
| WO2019067733A1 (en) * | 2017-09-27 | 2019-04-04 | Vividion Therapeutics, Inc. | COMPOUNDS AND METHODS FOR MODULATING PROTEIN DEGRADATION |
| WO2019075386A1 (en) | 2017-10-13 | 2019-04-18 | The Regents Of The University Of California | MODULATORS OF MTORC1 |
| HRP20230377T1 (hr) | 2017-11-15 | 2023-06-23 | Mirati Therapeutics, Inc. | Inhibitori mutacije kras g12c |
| US10647715B2 (en) | 2017-11-15 | 2020-05-12 | Mirati Therapeutics, Inc. | KRas G12C inhibitors |
| WO2019113724A1 (zh) * | 2017-12-11 | 2019-06-20 | 广州君赫生物科技有限公司 | 双硫仑的新应用 |
| US11932633B2 (en) | 2018-05-07 | 2024-03-19 | Mirati Therapeutics, Inc. | KRas G12C inhibitors |
| WO2020055761A1 (en) | 2018-09-10 | 2020-03-19 | Mirati Therapeutics, Inc. | Combination therapies |
| SMT202500028T1 (it) | 2018-09-10 | 2025-03-12 | Mirati Therapeutics Inc | Terapie combinate |
| CA3112043A1 (en) | 2018-09-10 | 2020-03-19 | Mirati Therapeutics, Inc. | Combination therapies |
| JP2022500385A (ja) | 2018-09-10 | 2022-01-04 | ミラティ セラピューティクス， インコーポレイテッド | 組み合わせ療法 |
| CN113164418A (zh) | 2018-12-05 | 2021-07-23 | 米拉蒂治疗股份有限公司 | 组合疗法 |
| WO2020146613A1 (en) | 2019-01-10 | 2020-07-16 | Mirati Therapeutics, Inc. | Kras g12c inhibitors |
| US12366579B2 (en) | 2019-03-21 | 2025-07-22 | University Of Virginia Patent Foundation | Sulfur-heterocycle exchange chemistry and uses thereof |
| EP4010459A4 (en) * | 2019-08-05 | 2023-09-06 | Bridgene Biosciences, Inc. | Method for proteome-wide discovery of covalent ligands and compositions thereof |
| WO2021041671A1 (en) | 2019-08-29 | 2021-03-04 | Mirati Therapeutics, Inc. | Kras g12d inhibitors |
| CN114761012B (zh) | 2019-09-24 | 2025-03-21 | 米拉蒂治疗股份有限公司 | 组合疗法 |
| EP4045920A4 (en) * | 2019-10-15 | 2023-10-11 | Jnana Therapeutics Inc. | INTERACTION DISCOVERY PLATFORM WITH A REACTIVE AFFINITY PROBE |
| CA3161949A1 (en) * | 2019-10-16 | 2021-04-22 | The Scripps Research Institute | An activity-guided map of electrophile-cysteine interactions in primary human immune cells |
| US20240123078A1 (en) * | 2019-10-16 | 2024-04-18 | Vividion Therapeutics, Inc. | Compounds and methods for modulating immune-related proteins |
| CN111063389B (zh) * | 2019-12-04 | 2021-10-29 | 浙江工业大学 | 一种基于深度卷积神经网络的配体绑定残基预测方法 |
| PH12022551513A1 (en) | 2019-12-20 | 2023-04-24 | Mirati Therapeutics Inc | Sos1 inhibitors |
| WO2022056307A1 (en) | 2020-09-11 | 2022-03-17 | Mirati Therapeutics, Inc. | Crystalline forms of a kras g12c inhibitor |
| CN112255396A (zh) * | 2020-10-15 | 2021-01-22 | 南开大学 | 一种测量小分子药物抑制蛋白核酸互作的单分子力学方法 |
| WO2022132200A1 (en) | 2020-12-15 | 2022-06-23 | Mirati Therapeutics, Inc. | Azaquinazoline pan-kras inhibitors |
| EP4262803A4 (en) | 2020-12-16 | 2025-03-12 | Mirati Therapeutics, Inc. | Tetrahydropyridopyrimidine pan-kras inhibitors |
| WO2022240966A1 (en) * | 2021-05-11 | 2022-11-17 | Opna Immuno-Oncology Sa | Compounds and methods for yap/tead modulation and indications therefor |
| WO2023092133A1 (en) * | 2021-11-22 | 2023-05-25 | The Scripps Research Institute | Stereoselective covalent ligands for oncogenic and immunological proteins |
| US20260079154A1 (en) * | 2022-09-12 | 2026-03-19 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Composition, device, system, and methods for detecting environmental toxicants |
| US20260103438A1 (en) * | 2022-09-28 | 2026-04-16 | The General Hospital Corporation | Probes and methods to identify ligandable fatty acylation sites for therapeutic target identification |
| CN116790698B (zh) * | 2023-06-21 | 2024-06-18 | 南京大学 | 基于氧化脱羧酶的硫醛合成方法及其应用 |
| WO2025182683A1 (ja) * | 2024-02-29 | 2025-09-04 | 国立大学法人 東京大学 | タンパク質の活性／反応性部位の、活性／反応性の評価方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6344330B1 (en) | 1998-03-27 | 2002-02-05 | The Regents Of The University Of California | Pharmacophore recombination for the identification of small molecule drug lead compounds |
| EP1185632A1 (en) * | 1999-06-10 | 2002-03-13 | PHARMACIA & UPJOHN COMPANY | Caspase-8 crystals, models and methods |
| AU2573102A (en) * | 2000-11-21 | 2002-06-03 | Sunesis Pharmaceuticals Inc | An extended tethering approach for rapid identification of ligands |
| WO2005118833A2 (en) | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with sterile-alpha motif and leucine zipper containing kinase (zak) |
| US7935479B2 (en) | 2004-07-19 | 2011-05-03 | Cell Biosciences, Inc. | Methods and devices for analyte detection |
| US8314215B2 (en) * | 2006-08-04 | 2012-11-20 | The Board Of Trustees Of The Leland Stanford Junior University | Mild chemically cleavable linker system |
| JPWO2008029924A1 (ja) * | 2006-09-08 | 2010-01-21 | 大日本住友製薬株式会社 | 環状アミノアルキルカルボキサミド誘導体 |
| US20090068107A1 (en) | 2006-10-02 | 2009-03-12 | The Scripps Research Institute | Enzyme regulating ether lipid signaling pathways |
| CN101219219B (zh) * | 2007-01-10 | 2013-02-13 | 北京普罗吉生物科技发展有限公司 | 包含血管抑素或其片段的复合物、其制备方法及应用 |
| EP1947193A1 (en) | 2007-01-17 | 2008-07-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Screening method for anti-diabetic compounds |
| CA2679643A1 (en) * | 2007-03-09 | 2008-09-18 | The University Of British Columbia | Procaspase 8-mediated disease targeting |
| EP2254574A1 (en) * | 2008-02-26 | 2010-12-01 | Ludwig-Maximilians-Universität München | Beta-lactones as antibacterial agents |
| US9907828B2 (en) * | 2012-06-22 | 2018-03-06 | The University Of Vermont And State Agricultural College | Treatments of oxidative stress conditions |
| EP3004141A4 (en) | 2013-06-03 | 2017-05-31 | Acetylon Pharmaceuticals, Inc. | Histone deacetylase ( hdac) biomarkers in multiple myeloma |
| US10782295B2 (en) | 2013-08-13 | 2020-09-22 | The Scripps Research Institute | Cysteine-reactive ligand discovery in proteomes |
| US10034892B2 (en) | 2014-08-21 | 2018-07-31 | Srx Cardio, Llc | Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity |
| JP6953400B2 (ja) * | 2015-10-22 | 2021-10-27 | ザ スクリプス リサーチ インスティテュート | システイン反応性プローブとその使用 |
| IL268101B2 (en) | 2017-01-18 | 2024-08-01 | Scripps Research Inst | Photoreactive ligands and their uses |
-
2016
- 2016-10-21 JP JP2018516113A patent/JP6953400B2/ja active Active
- 2016-10-21 CA CA3001847A patent/CA3001847A1/en active Pending
- 2016-10-21 US US15/331,745 patent/US10670605B2/en active Active
- 2016-10-21 EP EP16858391.2A patent/EP3365686A4/en not_active Withdrawn
- 2016-10-21 WO PCT/US2016/058308 patent/WO2017070611A1/en not_active Ceased
-
2020
- 2020-06-02 US US16/890,966 patent/US20200292555A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019501363A5 (https=) | ||
| Li et al. | Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling | |
| Humphery‐Smith et al. | Proteome research: complementarity and limitations with respect to the RNA and DNA worlds | |
| Eaton | Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures | |
| Nikolovska-Coleska | Studying protein-protein interactions using surface plasmon resonance | |
| Chen et al. | Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics | |
| Gasilova et al. | Analysis of major milk whey proteins by immunoaffinity capillary electrophoresis coupled with MALDI‐MS | |
| JP2011504596A (ja) | サンプル中の分析物を定量測定する際に使用するための内部標準および方法 | |
| ATE393912T1 (de) | Microarrays und ihre verwendungen | |
| Honoré et al. | Functional genomics studied by proteomics | |
| Billakanti et al. | Simultaneous, quantitative detection of five whey proteins in multiple samples by surface plasmon resonance | |
| Stigter et al. | Coupling surface-plasmon resonance and mass spectrometry to quantify and to identify ligands | |
| ATE554106T1 (de) | Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung | |
| JP2006517788A5 (https=) | ||
| Salimi-Moosavi et al. | Rapid affinity measurement of protein–protein interactions in a microfluidic platform | |
| Campion et al. | Protein quantitation and analysis of purity | |
| JP2016535270A5 (https=) | ||
| Xu et al. | On‐plate enrichment of glycopeptides by using boronic acid functionalized gold‐coated Si wafer | |
| Anders et al. | SPRi-MALDI MS: characterization and identification of a kinase from cell lysate by specific interaction with different designed ankyrin repeat proteins | |
| EP1589341A2 (en) | Method of selective peptide isolation for the identification and quantitative analysis of proteins in complex mixtures | |
| JP2005513507A5 (https=) | ||
| Houfani et al. | Review of the real and sometimes hidden costs in proteomics experimental workflows | |
| Ferry-Galow et al. | The root causes of pharmacodynamic assay failure | |
| Hobbs et al. | Biophysical and proteomic characterization strategies for cysteine modifications in Ras GTPases | |
| Yang et al. | Probing the interaction of nanoparticles with small molecules in real time via quartz crystal microbalance monitoring |